Quick Links

Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity

Physicians' Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669 for 2.0 Contact Hours.

Repurposing Statement

If you previously participated and received credit for the live CME/CE-certified webcast, School of Breast Oncology®: Mid-Year Video Update, which was held August 17, 2017, in Cranbury, New Jersey, please note that you will not receive credit for completing this activity. Participants who take part in an identical activity, even to validate learning or to clarify specific topics, cannot claim, nor will Physicians’ Education Resource®, LLC award, duplicate credit for the activity.

Acknowledgment of Commercial Support

This activity is supported by educational grants from Eisai Inc. and Lilly.

For further information concerning Lilly grant funding, visit

School of Breast Oncology®: Mid-Year Video Update Online

Release Date: September 30, 2017
Expiration Date: September 30, 2018
Media: Internet - based


Activity Overview

Since 2003, the School of Breast Oncology® (SOBO®) has revolutionized the advancement of patient care, and offers world-class continuing education programming for oncologists and healthcare professionals involved in the treatment of breast cancer. SOBO® emphasizes the latest in clinical data, from breast cancer diagnosis and screening to prevention and treatment.

Following 14 years of innovation and leadership, SOBO® continues to revolutionize the field of breast cancer education, and is proud to announce an educational extension to the conference: School of Breast Oncology®: Mid-Year Video Update. Mid-Year Video Update aired on August 17, 2017, as a live webcast, and enabled healthcare professionals from anywhere in the world to connect with leading experts to hear them discuss the latest clinical data and how to immediately incorporate advances into practice. This enduring CME activity is an archive of the live broadcast that has been edited into modules for ease of access.

SOBO®: Mid-Year Video Update brings conference-caliber education to the convenience of a screen!

Acknowledgment of Commercial Support

This activity is supported by educational grants from Eisai Inc. and Lilly.

For further information concerning Lilly grant funding, visit

CME/CE Activity Table of Contents

  • Introduction
  • New Advances in the Systemic Treatment of Early-Stage Breast Cancer
  • Panel Discussion
  • New Advances in the Systemic Treatment of Metastatic Breast Cancer
  • Panel Discussion
  • New Advances in Locoregional Control of Breast Cancer
  • Panel Discussion and Conclusion

Instructions for This Activity and Receiving Credit

  • You will need to login to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review videos/content until you finish the presentation.
  • At the end of the activity, “educational content/video files” will be available for your reference.
  • In order to receive a cme/ce certificate, participants must complete the activity.
  • Complete the posttest and pass with a score of 70% or higher, complete the evaluation and then click on request for credit. Participants may immediately download a cme/ce certificate upon completion of these steps.

Target Audience

This educational activity is directed toward medical oncologists, surgical oncologists, and radiation oncologists involved in the treatment and management of patients with breast cancer. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other healthcare professionals interested in the treatment of breast cancer may also participate.

Learning Objectives

At the conclusion of this activity, you should be better prepared to:

  • Review the design and endpoints of noteworthy clinical trial studies that are focused on evaluating novel strategies in breast cancer treatment and management
  • Assess emerging data and novel strategies in the treatment of patients with breast cancer
  • Discuss how emerging evidence regarding novel agents and evolving strategies can be placed into clinical context for the treatment of breast cancer

Faculty, Staff, and Planners' Disclosures

Program Director

Joyce O'Shaughnessy, MD
Celebrating Women Chair in Breast Cancer Research
Baylor University Medical Center
Texas Oncology
Chair, Breast Cancer Research Program
The US Oncology Network
Dallas, TX

Disclosure: Consultant: Arno Therapeutics, AstraZeneca, Celgene, Corcept Therapeutics, Eisai, Genentech, GlaxoSmithKline, Lilly, J&J, Merrimack, Novartis, Pfizer, Roche, Sanofi, Takeda, Medfusion


William J. Gradishar, MD, FASCO, FACP
Betsy Bramsen Professor of Breast Oncology
Interim Chief, Division of Hematology/Oncology
Robert H. Lurie Comprehensive Cancer Center of Feinberg School of Medicine
Northwestern University
Chicago, IL

Disclosure: No relevant financial relationships with commercial interests to disclose.

Eleftherios Mamounas, MD, MPH, FACS
Medical Director, Comprehensive Breast Program
UF Health Cancer Center - Orlando Health
Orlando, FL

Disclosure: Consultant: Genomic Health Inc, Genentech, Pfizer, Novartis, Biotheranostics, Bayer, GRAIL, Cellucity; Speaker’s Bureau: Genomic Health Inc, Genentech/Roche

Joseph Sparano, MD
Professor of Medicine & Women’s Health
Albert Einstein College of Medicine
Montefiore Medical Center
Bronx, NY

Disclosure: Grant/Research Support: Deciphera, Prescient; Consultant: Genentech, Eli Lilly, Pfizer, Juno, AstraZeneca, Novartis; Stock/Shareholder: MetaStat

The staff of PER® have no relevant financial relationships with commercial interests to disclose.

Disclosure Policy and Resolution of Conflicts of Interest (COI)

As a sponsor accredited by the ACCME, it is the policy of PER® to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME/CE activities. In compliance with ACCME guidelines, PER® requires everyone who is in a position to control the content of a CME/CE activity to disclose all relevant financial relationships with commercial interests. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that creates a COI.

Additionally, PER® is required by ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This CME/CE activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME/CE activity is for continuing medical and nursing education purposes only, and is not meant to substitute for the independent clinical judgment of a physician relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER®.

CME/CE Provider Contact Information

Physicians’ Education Resource®, LLC
2 Clarke Drive
Suite 110
Cranbury, NJ 08512

Hardware And Software Requirements 

Supported Browsers
Internet Explorer v.7 or greater (for Windows) | Mozilla Firefox v.2 or greater (for Windows, Mac, Linux)

Minimum System Requirements (Windows)

  • A Pentium-based PC or compatible computer
  • At least 64MB of RAM
  • Windows 95/98/NT/ME/2000/XP/Vista system software
  • Screen resolution of 1024 x 786 or larger recommended
  • PDF Reader: Adobe Reader 5.0 or higher, Foxit Reader 2.0 or likewise

Minimum System Requirements (Mac OS)

  • A PowerPC processor-based Macintosh computer
  • At least 64MB of RAM
  • Mac OS 7.5 or later
  • Screen resolution of 1024 x 786 or larger recommended
  • PDF Reader: Adobe Reader 5.0 or higher, Foxit Reader 2.0 or likewise

Become a Member

Forgot Password?
Calendar of Events
Filter By